Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety
Authors
Keywords
Etanercept, Juvenile Idiopathic Arthritis, Abatacept, Aflibercept, Central Retinal Vein Occlusion
Journal
DRUG SAFETY
Volume 38, Issue 5, Pages 455-479
Publisher
Springer Nature
Online
2015-04-03
DOI
10.1007/s40264-015-0285-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fc fusion as a platform technology: potential for modulating immunogenicity
- (2015) Ditza Levin et al. TRENDS IN BIOTECHNOLOGY
- Lymphopenia induced by etanercept
- (2014) Amber N. Pepper et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort
- (2014) Matteo Piga et al. AUTOIMMUNITY REVIEWS
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- Hypersensitivity Reactions to Biologic Agents
- (2014) Alessandra Vultaggio et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Psoriasiform reactions during treatment with abatacept
- (2014) Elena Conde-Montero et al. Indian Journal of Dermatology Venereology & Leprology
- Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis: Longterm Data from the ACQUIRE Trial
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry
- (2014) Lei Zhu et al. mAbs
- A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
- (2014) Tomohiro Kameda et al. Modern Rheumatology
- Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept
- (2014) Hiroyuki Sakaida et al. Modern Rheumatology
- Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
- (2014) Jeffrey S. Heier et al. OPHTHALMOLOGY
- A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer
- (2013) H Chen et al. BRITISH JOURNAL OF CANCER
- Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch
- (2013) Brian A. Baldo et al. CANCER AND METASTASIS REVIEWS
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
- (2013) Josep Tabernero et al. EUROPEAN JOURNAL OF CANCER
- Anaphylaxis to Etanercept in Two Children With Juvenile Idiopathic Arthritis
- (2013) Courtney B. Crayne et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Successful Etanercept Desensitization in a Patient With Severe Injection Site Reactions
- (2013) Joanna Hall et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Abatacept in B7-1–Positive Proteinuric Kidney Disease
- (2013) Chih-Chuan Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion
- (2013) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
- (2013) Essack Mitha et al. RHEUMATOLOGY
- Analytical characterization of biosimilar antibodies and Fc-fusion proteins
- (2013) Alain Beck et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
- (2013) Robert A Terkeltaub et al. ARTHRITIS RESEARCH & THERAPY
- Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses
- (2013) Brian Baldo OncoImmunology
- Summary of the US FDA Approval of Belatacept
- (2012) P. Archdeacon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study
- (2012) Hal M. Hoffman et al. CLINICAL THERAPEUTICS
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Etanercept Allergy and Anaphylaxis
- (2012) A. QUISMORIO et al. JOURNAL OF RHEUMATOLOGY
- Peptibodies: A flexible alternative format to antibodies
- (2012) Grant Shimamoto et al. mAbs
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Leucopenia e trombocitopenia induzidas por etanercepte: relato de dois casos e revisão da literatura
- (2012) Valderílio Feijó Azevedo et al. Revista Brasileira De Reumatologia
- Psoriasiform Drug Eruption due to Abatacept
- (2011) T Satoh et al. ACTA DERMATO-VENEREOLOGICA
- Injection-site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization
- (2011) S. Bavbek et al. ALLERGY
- Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab
- (2011) Ilaria Puxeddu et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Treatment of Refractory Tumor Necrosis Factor Inhibitor –Induced Palmoplantar Pustulosis: A Report of 2 Cases
- (2011) Derek H. Chu ARCHIVES OF DERMATOLOGY
- Etanercept
- (2011) Lidian L. A. Lecluse et al. ARCHIVES OF DERMATOLOGY
- A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia
- (2011) J. B. Bussel et al. BLOOD
- Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
- (2011) M. Khellaf et al. BLOOD
- Re-challenge with Etanercept in patients with Etanercept-induced Neutropenia
- (2011) Muhammad Haroon et al. CLINICAL RHEUMATOLOGY
- A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept
- (2011) Yuki Ishikawa et al. CLINICAL RHEUMATOLOGY
- Effectiveness and Safety of Etanercept in Patients with Psoriatic Arthritis in a Canadian Clinical Practice Setting: The REPArE Trial
- (2011) D. D. GLADMAN et al. JOURNAL OF RHEUMATOLOGY
- Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation
- (2011) M. Konsta et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies
- (2011) Alain Beck et al. mAbs
- Reversible bone marrow reticulin fibrosis as a side effect of romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia
- (2011) Teresa Leung et al. PATHOLOGY
- Belatacept: A Novel Biologic for Maintenance Immunosuppression After Renal Transplantation
- (2011) Spencer T Martin et al. PHARMACOTHERAPY
- Urticaria Due to Etanercept in a Patient with Psoriatic Arthritis
- (2011) Joaquín Borrás-Blasco et al. SOUTHERN MEDICAL JOURNAL
- Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
- (2011) Nigel M. Stapleton et al. Nature Communications
- Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients
- (2010) R. Ferguson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
- (2010) A. Durrbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- SEVERE GENERALIZED EXANTHEMA DUE TO ETANERCEPT GIVEN FOR SEVERE PLAQUE PSORIASIS
- (2010) M Angeles Gonzalo-Garijo et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker
- (2010) Christian Renaud et al. EUROPEAN JOURNAL OF PEDIATRICS
- Long-term etanercept in pediatric patients with plaque psoriasis
- (2010) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Etanercept: effectiveness and safety data of a retrospective study
- (2010) C. Antoniou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
- (2010) David J. Kuter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe pneumonia by aciclovir-resistant varicella-zoster virus during etanercept therapy
- (2010) V. Manzano et al. RHEUMATOLOGY
- BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
- (2010) T. Ding et al. RHEUMATOLOGY
- Echinococcus multilocularis infection and TNF inhibitor treatment in a patient with rheumatoid arthritis
- (2010) S. M. Weiner et al. RHEUMATOLOGY INTERNATIONAL
- Neutropenia in patients receiving anti-tumor necrosis factor therapy
- (2010) Richard Hastings et al. ARTHRITIS CARE & RESEARCH
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Angio-oedema in a Patient Treated with Etanercept for Rheumatoid Arthritis
- (2009) Omer Faruk Sendur et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
- (2009) A. Craig Lockhart et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
- (2009) Kristi Baker et al. Seminars in Immunopathology
- Thrombopoietin and Thrombopoietin Mimetics in the Treatment of Thrombocytopenia
- (2008) David J. Kuter Annual Review of Medicine
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Ophthalmic manifestations of demyelination secondary to etanercept
- (2008) CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Tumor necrosis factor antagonists in the therapy of psoriasis
- (2008) Rotraut Mössner et al. CLINICS IN DERMATOLOGY
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Rapid Onset and Fatal Outcome of Two Squamous Cell Carcinomas of the Genitalia in a Patient Treated with Etanercept for Cutaneous Psoriasis
- (2008) Christelle Comte et al. DERMATOLOGY
- Recurrent Varicella in an Adult Psoriasis Patient Treated with Etanercept
- (2008) S. Becart et al. DERMATOLOGY
- TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome
- (2008) O. Kastrup et al. JOURNAL OF NEUROLOGY
- Angiokeratoma induced by injection of etanercept for psoriasis
- (2008) Emilie Bathelier et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept
- (2008) S Daulat et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
- (2008) David J Kuter et al. LANCET
- Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
- (2008) Amy S. Paller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dependence of antibody-mediated presentation of antigen on FcRn
- (2008) S.-W. Qiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lupus érythémateux cutané induit par étanercept au cours de la polyarthrite rhumatoïde
- (2008) F.E. Abourazzak et al. REVUE DE MEDECINE INTERNE
- Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis
- (2008) P. Watson et al. RHEUMATOLOGY
- Focus on adverse events of tumour necrosis factor blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
- (2007) V Gerloni et al. ANNALS OF THE RHEUMATIC DISEASES
- Exacerbation of interstitial lung disease during etanercept therapy: Two cases
- (2007) Anne Tournadre et al. JOINT BONE SPINE
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started